Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
brilliant green cation
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Brilliant green cation is the active component of the synthetic dye "brilliant green," a triarylmethane derivative used primarily as a topical antiseptic and antibacterial agent. It inhibits the growth of Gram-positive bacteria and is commonly found in solutions or swabs to prevent infection, especially for skin abrasions, scratches, and umbilical cord care in newborns. Brilliant green also serves as a histological stain, fluorochrome, and environmental contaminant. Its mechanism of action involves disruption of bacterial cell growth[1][2][5][8].
- Other names
- brilliant greenC.I. Basic Green 1Basic Green 1Malachite Green GEmeraldSolid greenDiamond green GAniline greenBenzaldehyde greenFast green J
Beyond the preview
Go deeper on brilliant green cation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on brilliant green cation.